1. Home
  2. ORIC vs CARE Comparison

ORIC vs CARE Comparison

Compare ORIC & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • CARE
  • Stock Information
  • Founded
  • ORIC 2014
  • CARE 1974
  • Country
  • ORIC United States
  • CARE United States
  • Employees
  • ORIC N/A
  • CARE N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • CARE Major Banks
  • Sector
  • ORIC Health Care
  • CARE Finance
  • Exchange
  • ORIC Nasdaq
  • CARE Nasdaq
  • Market Cap
  • ORIC 362.9M
  • CARE 330.3M
  • IPO Year
  • ORIC 2020
  • CARE N/A
  • Fundamental
  • Price
  • ORIC $4.77
  • CARE $14.82
  • Analyst Decision
  • ORIC Strong Buy
  • CARE Buy
  • Analyst Count
  • ORIC 9
  • CARE 2
  • Target Price
  • ORIC $18.43
  • CARE $21.50
  • AVG Volume (30 Days)
  • ORIC 969.8K
  • CARE 78.6K
  • Earning Date
  • ORIC 05-05-2025
  • CARE 04-28-2025
  • Dividend Yield
  • ORIC N/A
  • CARE N/A
  • EPS Growth
  • ORIC N/A
  • CARE 6.25
  • EPS
  • ORIC N/A
  • CARE 1.06
  • Revenue
  • ORIC N/A
  • CARE $140,871,000.00
  • Revenue This Year
  • ORIC N/A
  • CARE $11.93
  • Revenue Next Year
  • ORIC N/A
  • CARE $13.02
  • P/E Ratio
  • ORIC N/A
  • CARE $13.98
  • Revenue Growth
  • ORIC N/A
  • CARE 4.98
  • 52 Week Low
  • ORIC $3.90
  • CARE $10.95
  • 52 Week High
  • ORIC $14.67
  • CARE $20.40
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 37.10
  • CARE 42.27
  • Support Level
  • ORIC $3.90
  • CARE $13.61
  • Resistance Level
  • ORIC $5.38
  • CARE $14.88
  • Average True Range (ATR)
  • ORIC 0.53
  • CARE 0.74
  • MACD
  • ORIC 0.06
  • CARE -0.01
  • Stochastic Oscillator
  • ORIC 41.97
  • CARE 43.06

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About CARE Carter Bankshares Inc.

Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.

Share on Social Networks: